Literature DB >> 27446407

Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.

Tomonori Kato1, Akira Komiya1, Akihiro Morii1, Hiroaki Iida1, Takatoshi Ito1, Hideki Fuse1.   

Abstract

Saturation prostate biopsy protocols have been developed to improve the prostate cancer (PCa) detection rate, particularly in the setting of repeat biopsies. The present study attempted to clarify the association between PCa detection and various risk factors in repeat saturation biopsies. A retrospective analysis was conducted on 78 Japanese patients for whom findings had caused suspicion of PCa despite previous negative prostate biopsies, and who consecutively underwent a 24-core transperineal repeat biopsy at Toyama University Hospital (Toyama, Japan). PCa was confirmed histologically in 16 of the 78 patients (20.5%). A univariate analysis revealed that the prostate-specific antigen (PSA) level at repeat biopsy was higher (P<0.01), the fPSA/tPSA ratio was lower (P=0.04), the total prostate volume was smaller (P=0.01) and the PSA density was higher (P<0.01) in PCa patients than in patients with benign prostatic disease (BPD). Histological inflammation was more frequently observed in BPD patients than in PCa patients (P<0.01). A multivariate analysis revealed that histological inflammation was the only independent predictor of the presence of a malignant lesion on repeat biopsy (odds ratio, 0.027; P=0.01). It must be considered that inflammation may cause a PSA increase in some patients with a negative initial biopsy, leading to unnecessary repeat biopsy.

Entities:  

Keywords:  histological inflammation; prostate cancer; repeat biopsy; saturation biopsy; transperineal biopsy

Year:  2016        PMID: 27446407      PMCID: PMC4950658          DOI: 10.3892/ol.2016.4693

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

1.  Follow-up of atypical prostate needle biopsies suspicious for cancer.

Authors:  T Y Chan; J I Epstein
Journal:  Urology       Date:  1999-02       Impact factor: 2.649

2.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

3.  The presence of atypical small acinar proliferation in prostate needle biopsy is predictive of carcinoma on subsequent biopsy.

Authors:  R C Ouyang; D N Kenwright; J N Nacey; B Delahunt
Journal:  BJU Int       Date:  2001-01       Impact factor: 5.588

4.  Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

Authors:  Jeffrey J Tosoian; Bruce J Trock; Patricia Landis; Zhaoyong Feng; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

5.  Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.

Authors:  Bob Djavan; Yan Kit Fong; Vincent Ravery; Mesut Remzi; Wolfgang Horninger; Martin Susani; Soren Kreuzer; Laurent Boccon-Gibod; Georg Bartsch; Michael Marberger
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

6.  Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.

Authors:  P H Schatteman; L Hoekx; J J Wyndaele; W Jeuris; E Van Marck
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

7.  High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.

Authors:  Kamran P Sajadi; Timothy Kim; Martha K Terris; James A Brown; Ronald W Lewis
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

8.  Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.

Authors:  Onder Yaman; Cağatay Göğüş; Ozden Tulunay; Zafer Tokatli; Eriz Ozden
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

9.  Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis.

Authors:  Patrick J Bastian; Leslie A Mangold; Jonathan I Epstein; Alan W Partin
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

10.  Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.

Authors:  Masahiko Inahara; Hiroyoshi Suzuki; Hiroshi Nakamachi; Naoto Kamiya; Masaki Shimbo; Akira Komiya; Takeshi Ueda; Tomohiko Ichikawa; Koichiro Akakura; Haruo Ito
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.